Published November 2018 | Version v1
Journal article

Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-κB pathways

  • 1. Hunan University of Chinese Medicine, Changsha, 410208, PR (China)
  • 2. Department of Geriatrics, The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, 410007, PR (China)

Description

Highlights: • ISL reversed Ang II-induced inhibition of cell survival, cell cycle arrest and cell apoptosis in HK-2 cells. • Nrf2-mediated oxidative stress was involved in the regulation of Ang II-induced apoptosis by ISL. • ISL inhibited Ang II-induced NF-κB signaling activation and inflammatory cytokines release. • ISL inhibited Ang II-induced excessive deposition of extracellular matrix. Hypertensive renal injury plays important role in the pathogenesis of end-stage nephropathy and the need for dialysis. Isoliquiritigenin (ISL) is a natural compound with antioxidant and anti-inflammatory activities. In this study, the protective effects of ISL on Angiotensin II (Ang II)- induced apoptosis, inflammation and extracellular matrix production in HK-2 cells were observed and its mechanisms were elucidated.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2018.09.013

Additional details

Identifiers

DOI
10.1016/j.bbrc.2018.09.013;
PII
S0006291X18319235;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
506
Journal Issue
1
Journal Page Range
p. 161-168
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53017089
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ANGIOTENSIN; ANTIOXIDANTS; CELL CYCLE; DIALYSIS; INFLAMMATION; KIDNEYS; LYMPHOKINES
Descriptors DEC
BODY; CARDIOVASCULAR AGENTS; DRUGS; GLOBULINS; GROWTH FACTORS; MITOGENS; ORGANIC COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; PROTEINS; SEPARATION PROCESSES; SYMPTOMS; VASOCONSTRICTORS

Optional Information

Copyright
Copyright (c) 2018 Published by Elsevier Inc.